JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roh, J.-L.
Right arrow Articles by Kim, S. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roh, J.-L.
Right arrow Articles by Kim, S. Y.
Journal of Nuclear Medicine Vol. 48 No. 2 240-246
© 2007 by Society of Nuclear Medicine


Clinical Investigation

Clinical Utility of 18F-FDG PET for Patients with Salivary Gland Malignancies

Jong-Lyel Roh1, Chang Hwan Ryu1, Seung-Ho Choi1, Jae Seung Kim2, Jeong Hyun Lee3, Kyung-Ja Cho4, Soon Yuhl Nam1 and Sang Yoon Kim1

1 Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; 2 Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; 3 Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; and 4 Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Correspondence: For correspondence contact: Jong-Lyel Roh, MD, PhD, Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Pungnap-dong, Songpa-gu, Seoul 138-736, South Korea. E-mail: rohjl{at}amc.seoul.kr

The clinical utility of 18F-FDG PET in evaluating salivary gland malignancies has not been well defined. We therefore evaluated the utility of 18F-FDG PET in management for patients with salivary gland cancers. Methods: Thirty-four patients with newly diagnosed salivary gland cancers underwent CT and 18F-FDG PET before surgical resection with radiotherapy. The diagnostic accuracies of CT and 18F-FDG PET for detecting primary tumors and neck metastases were compared with a histopathologic reference. We determined the relationship between the maximum standardized uptake value (SUV) of the tumor and clinicopathologic parameters such as sex, age, local tumor invasion, T and N categories, TNM stage, and histologic grade, as well as their associations with disease-free survival (DFS). Results: 18F-FDG PET was more sensitive than CT for the detection of primary tumors (91.2% vs. 79.4%; P < 0.05), cervical metastases (80.5% vs. 56.1%; P < 0.05), and distant metastases in 2 patients at initial staging. High-grade malignancies had higher mean maximum SUVs than did low- and intermediate-grade malignancies (4.6 vs. 2.8; P = 0.011). T and N categories were independent determinants of DFS (P < 0.05), but the maximum SUV (4.0) was not. During a mean follow-up of 25.1 mo, 18F-FDG PET correctly diagnosed local–regional recurrences in 6 patients and new distant metastases in 9 patients. Conclusion: Our findings indicate that, in patients with salivary gland malignancies, 18F-FDG PET is clinically useful in initial staging, histologic grading, and monitoring after treatment but not in predicting patient survival.

Key Words: salivary gland cancer • 18F-FDG PET • staging • histologic grading • predictive factor • standardized uptake value

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11a-12a. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. Y. Jeong, K. S. Lee, J. Han, B.-T. Kim, T. S. Kim, Y. M. Shim, and J. Kim
Integrated PET/CT of Salivary Gland Type Carcinoma of the Lung in 12 Patients
Am. J. Roentgenol., December 1, 2007; 189(6): 1407 - 1413.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H.-S. Jeong, M. K. Chung, Y.-I. Son, J. Y. Choi, H. J. Kim, Y. H. Ko, and C.-H. Baek
Role of 18F-FDG PET/CT in Management of High-Grade Salivary Gland Malignancies
J. Nucl. Med., August 1, 2007; 48(8): 1237 - 1244.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.